title: Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles.
abstract: The intronless N-myc2 gene was originally identified as the major target of hepatitis virus insertion in woodchuck liver tumors. Here we report that transgenic mice carrying the N-myc2 gene controlled by woodchuck hepatitis virus (WHV) regulatory sequences are highly predisposed to liver cancer. In a WHV/N-myc2 transgenic line, hepatocellular carcinomas or adenomas arose in over 70% of mice, despite barely detectable expression of the methylated transgene in liver cells. Furthermore, a transgenic founder carrying unmethylated transgene sequences succumbed to a large liver tumor by the age of two months, demonstrating the high oncogenicity of the woodchuck N-myc2 retroposon. Stabilizing mutations or deletions of beta-catenin were found in 25% of liver tumors and correlated with reduced tumor latency (P<0.05), confirming the important role of beta-catenin activation in Myc-induced tumorigenesis. The ability of the tumor suppressor gene p53 to cooperate with N-myc2 in liver cell transformation was tested by introducing a p53-null allele into WHV/N-myc2 transgenic mice. The loss of one p53 allele in transgenic animals markedly accelerated the onset of liver cancer (P=0.0001), and most tumors of WHV/N-myc2 p53+/Delta mice harbored either a deletion of the wt p53 allele or a beta-catenin mutation. These findings provide direct evidence that activation of N-myc2 and reduction of p53 levels act synergistically during multistage carcinogenesis in vivo and suggest that different genetic pathways may underlie liver carcinogenesis initiated by a myc transgene. Oncogene (2000).
authors.affiliation: Unité de Recombinaison et Expression Génétique (INSERM U163), Institut Pasteur, 28 rue du Dr. Roux, 75015 Paris, France.
authors.forename: C A
authors.initials: CA
authors.lastname: Renard
authors.forename: G
authors.initials: G
authors.lastname: Fourel
authors.forename: M P
authors.initials: MP
authors.lastname: Bralet
authors.forename: C
authors.initials: C
authors.lastname: Degott
authors.forename: A
authors.initials: A
authors.lastname: De La Coste
authors.forename: C
authors.initials: C
authors.lastname: Perret
authors.forename: P
authors.initials: P
authors.lastname: Tiollais
authors.forename: M A
authors.initials: MA
authors.lastname: Buendia
mesh_terms: D000818:Animals; D003598:Cytoskeletal Proteins / Q000235:genetics*; D015972:Gene Expression Regulation, Neoplastic; D016259:Genes, myc; D016158:Genes, p53; D008114:Liver Neoplasms, Experimental / Q000235:genetics*; D051379:Mice; D008822:Mice, Transgenic; D015534:Trans-Activators / Q000235:genetics*; D014764:Viral Proteins / Q000235:genetics*; D051176:beta Catenin
chemical_list: C495267:CTNNB1 protein, mouse; D003598:Cytoskeletal Proteins; D015534:Trans-Activators; D014764:Viral Proteins; D051176:beta Catenin; C090237:protein X, Woodchuck hepatitis B virus